|
1
|
Silverberg JI and Hanifin JM: Adult eczema
prevalence and associations with asthma and other health and
demographic factors: A US population-based study. J Allergy Clin
Immunol. 132:1132–1138. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hay RJ, Johns NE, Williams HC, Bolliger
IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA,
Wulf SK, et al: The global burden of skin disease in 2010: An
analysis of the prevalence and impact of skin conditions. J Invest
Dermatol. 134:1527–1534. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Patrick GJ, Archer NK and Miller LS: Which
way do we go? Complex interactions in atopic dermatitis
pathogenesis. J Invest Dermatol. 141:274–284. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Langan SM, Irvine AD and Weidinger S:
Atopic dermatitis. Lancet. 396:345–360. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
De Benedetto A, Kubo A and Beck LA: Skin
barrier disruption: A requirement for allergen sensitization? J
Invest Dermatol. 132:949–963. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bangert C, Rindler K, Krausgruber T, Alkon
N, Thaler FM, Kurz H, Ayub T, Demirtas D, Fortelny N,
Vorstandlechner V, et al: Persistence of mature dendritic cells,
T(H)2A and Tc2 cells characterize clinically resolved atopic
dermatitis under IL-4Rα blockade. Sci Immunol.
6(eabe2749)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wongvibulsin S, Sutaria N, Kannan S,
Alphonse MP, Belzberg M, Williams KA, Brown ID, Choi J, Roh YS,
Pritchard T, et al: Transcriptomic analysis of atopic dermatitis in
African Americans is characterized by Th2/Th17-centered cutaneous
immune activation. Sci Rep. 11(11175)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gross N, Kropp J and Khatib H: MicroRNA
signaling in embryo development. Biology (Basel).
6(34)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chang J, Zhou B, Wei Z and Luo Y: IL-32
promotes the occurrence of atopic dermatitis by activating the
JAK1/microRNA-155 axis. J Transl Med. 20(207)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang X, Chen Y, Yuan W, Yao L, Wang S, Jia
Z, Wu P, Li L, Wei P, Wang X and Hong M: MicroRNA-155-5p is a key
regulator of allergic inflammation, modulating the epithelial
barrier by targeting PKIα. Cell Death Dis. 10(884)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sonkoly E, Janson P, Majuri ML, Savinko T,
Fyhrquist N, Eidsmo L, Xu N, Meisgen F, Wei T, Bradley M, et al:
MiR-155 is overexpressed in patients with atopic dermatitis and
modulates T-cell proliferative responses by targeting cytotoxic T
lymphocyte-associated antigen 4. J Allergy Clin Immunol.
126:581–589. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tsoi LC, Rodriguez E, Degenhardt F,
Baurecht H, Wehkamp U, Volks N, Szymczak S, Swindell WR, Sarkar MK,
Raja K, et al: Atopic dermatitis is an IL-13-dominant disease with
greater molecular heterogeneity compared to psoriasis. J Invest
Dermatol. 139:1480–1489. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Möbus L, Rodriguez E, Harder I, Stölzl D,
Boraczynski N, Gerdes S, Kleinheinz A, Abraham S, Heratizadeh A,
Handrick C, et al: Atopic dermatitis displays stable and dynamic
skin transcriptome signatures. J Allergy Clin Immunol. 147:213–223.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43(e47)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang LY, Li ST, Lin SC, Kao CH, Hong CH,
Lee CH and Yang LT: Gasdermin a is required for epidermal
cornification during skin barrier regeneration and in an atopic
dermatitis-like model. J Invest Dermatol. 143:1735–1745.
2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jiang Y, Tsoi LC, Billi AC, Ward NL, Harms
PW, Zeng C, Maverakis E, Kahlenberg JM and Gudjonsson JE:
Cytokinocytes: The diverse contribution of keratinocytes to immune
responses in skin. JCI Insight. 5(e142067)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Testa U, Pelosi E, Castelli G and Labbaye
C: miR-146 and miR-155: Two key modulators of immune response and
tumor development. Noncoding RNA. 3(22)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jankauskas SS, Gambardella J, Sardu C,
Lombardi A and Santulli G: Functional role of miR-155 in the
pathogenesis of diabetes mellitus and its complications. Noncoding
RNA. 7(39)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Eissa MG and Artlett CM: The microRNA
miR-155 is essential in fibrosis. Noncoding RNA.
5(23)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hu C, Liao J, Huang R, Su Q and He L:
MicroRNA-155-5p in serum derived-exosomes promotes
ischaemia-reperfusion injury by reducing CypD ubiquitination by
NEDD4. ESC Heart Fail. 10:1144–1157. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Toshitani A, Ansel JC, Chan SC, Li SH and
Hanifin JM: Increased interleukin 6 production by T cells derived
from patients with atopic dermatitis. J Invest Dermatol.
100:299–304. 1993.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tang L and Zhou F: Inflammasomes in common
immune-related skin diseases. Front Immunol. 11(882)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bernard M, Carrasco C, Laoubi L, Guiraud
B, Rozières A, Goujon C, Duplan H, Bessou-Touya S, Nicolas JF,
Vocanson M and Galliano MF: IL-1β induces thymic stromal
lymphopoietin and an atopic dermatitis-like phenotype in
reconstructed healthy human epidermis. J Pathol. 242:234–245.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Barker KR, Lu Z, Kim H, Zheng Y, Chen J,
Conroy AL, Hawkes M, Cheng HS, Njock MS, Fish JE, et al: MiR-155
modifies inflammation, endothelial activation and blood-brain
barrier dysfunction in cerebral malaria. Mol Med. 23:24–33.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ollague JE and Nousari CH: Expression of
elafin in dermatitis herpetiformis. Am J Dermatopathol. 40:1–6.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Moreau T, Baranger K, Dade S,
Dallet-Choisy S, Guyot N and Zani ML: Multifaceted roles of human
elafin and secretory leukocyte proteinase inhibitor (SLPI), two
serine protease inhibitors of the chelonianin family. Biochimie.
90:284–295. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Teng G, Liu Z, Liu Y, Wu T, Dai Y, Wang H
and Wang W: Probiotic escherichia coli nissle 1917 expressing
elafin protects against inflammation and restores the gut
microbiota. Front Microbiol. 13(819336)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li K, Zhang F, Wei L, Han Z, Liu X, Pan Y,
Guo C and Han W: Recombinant human elafin ameliorates chronic
hyperoxia-induced lung injury by inhibiting nuclear factor-kappa B
signaling in neonatal mice. J Interferon Cytokine Res. 40:320–330.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Elgharib I, Khashaba SA, Elsaid HH and
Sharaf MM: Serum elafin as a potential inflammatory marker in
psoriasis. Int J Dermatol. 58:205–209. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Brunner PM, He H, Pavel AB, Czarnowicki T,
Lefferdink R, Erickson T, Canter T, Puar N, Rangel SM, Malik K, et
al: The blood proteomic signature of early-onset pediatric atopic
dermatitis shows systemic inflammation and is distinct from adult
long-standing disease. J Am Acad Dermatol. 81:510–519.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
He YY, Zhou HF, Chen L, Wang YT, Xie WL,
Xu ZZ, Xiong Y, Feng YQ, Liu GY, Li X, et al: The Fra-1: Novel role
in regulating extensive immune cell states and affecting
inflammatory diseases. Front Immunol. 13(954744)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mishra RK, Potteti HR, Tamatam CR,
Elangovan I and Reddy SP: c-Jun is required for nuclear
factor-kappaB-dependent, LPS-stimulated fos-related antigen-1
transcription in alveolar macrophages. Am J Respir Cell Mol Biol.
55:667–674. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Moon YM, Lee SY, Kwok SK, Lee SH, Kim D,
Kim WK, Her YM, Son HJ, Kim EK, Ryu JG, et al: The fos-related
antigen 1-JUNB/Activator protein 1 transcription complex, a
downstream target of signal transducer and activator of
transcription 3, induces t helper 17 differentiation and promotes
experimental autoimmune arthritis. Front Immunol.
8(1793)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Korbecki J, Barczak K, Gutowska I, Chlubek
D and Baranowska-Bosiacka I: CXCL1: Gene, promoter, regulation of
expression, mRNA stability, regulation of activity in the
intercellular space. Int J Mol Sci. 23(792)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Korbecki J, Maruszewska A, Bosiacki M,
Chlubek D and Baranowska-Bosiacka I: The potential importance of
CXCL1 in the physiological state and in noncancer diseases of the
cardiovascular system, respiratory system and skin. Int J Mol Sci.
24(205)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhu Y, Yang S, Zhao N, Liu C, Zhang F, Guo
Y and Liu H: CXCL8 chemokine in ulcerative colitis. Biomed
Pharmacother. 138(111427)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kamsteeg M, Jansen PA, van Vlijmen-Willems
IM, van Erp PE, Rodijk-Olthuis D, van der Valk PG, Feuth T, Zeeuwen
PL and Schalkwijk J: Molecular diagnostics of psoriasis, atopic
dermatitis, allergic contact dermatitis and irritant contact
dermatitis. Br J Dermatol. 162:568–578. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hulshof L, Hack DP, Hasnoe Q, Dontje B,
Jakasa I, Riethmüller C, McLean WHI, van Aalderen WMC, Van't Land
B, Kezic S, et al: A minimally invasive tool to study immune
response and skin barrier in children with atopic dermatitis. Br J
Dermatol. 180:621–630. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T,
Chen Y, Han X and Wu K: The CXCL8-CXCR1/2 pathways in cancer.
Cytokine Growth Factor Rev. 31:61–71. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
DiStasi MR and Ley K: Opening the
flood-gates: How neutrophil-endothelial interactions regulate
permeability. Trends Immunol. 30:547–556. 2009.PubMed/NCBI View Article : Google Scholar
|
